Skip to Content

iRhythm Technologies Inc IRTC

Morningstar Rating
$112.12 +0.63 (0.57%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IRTC is trading at a 25% discount.
Price
$111.96
Fair Value
$674.26
Uncertainty
Very High
1-Star Price
$553.64
5-Star Price
$526.82
Economic Moat
Xvsx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IRTC is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$111.49
Day Range
$109.86114.47
52-Week Range
$70.24140.23
Bid/Ask
$44.87 / $117.69
Market Cap
$3.49 Bil
Volume/Avg
261,500 / 467,305

Key Statistics

Price/Earnings (Normalized)
Price/Sales
6.81
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
2,000

Comparables

Valuation

Metric
IRTC
OM
RXST
Price/Earnings (Normalized)
Price/Book Value
16.180.8512.24
Price/Sales
6.810.7921.01
Price/Cash Flow
64.56
Price/Earnings
No chart available

Financial Strength

Metric
IRTC
OM
RXST
Quick Ratio
1.824.277.05
Current Ratio
2.155.268.06
Interest Coverage
−34.29−13.39−15.68
Quick Ratio
IRTC
OM
RXST

Profitability

Metric
IRTC
OM
RXST
Return on Assets (Normalized)
−22.20%−39.03%−17.04%
Return on Equity (Normalized)
−43.24%−72.89%−21.78%
Return on Invested Capital (Normalized)
−27.84%−44.98%−20.20%
Return on Assets
IRTC
OM
RXST
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesMrtzfyhdTtzfw$183.8 Bil
SYK
Stryker CorpHmvhxzsdcgMrd$127.8 Bil
MDT
Medtronic PLCYrzzhqplrWtgtjcj$105.0 Bil
BSX
Boston Scientific CorpMqkrspltfYznxpl$99.9 Bil
EW
Edwards Lifesciences CorpJqxgntprYgjpqt$52.5 Bil
DXCM
DexCom IncFsyxxrckhXztbn$51.9 Bil
ZBH
Zimmer Biomet Holdings IncGlwmcxvzXhjs$24.9 Bil
ALGN
Align Technology IncPjytdnpkBwnhsz$22.6 Bil
PHG
Koninklijke Philips NV ADRHprnzmnsLypnht$18.2 Bil
PODD
Insulet CorpByrnzkmspRzgpjln$11.6 Bil

Sponsor Center